(firstQuint)Bupropion for the Treatment of Methamphetamine Dependence - 1.

 A double-blind, placebo-controlled, parallel-group design study in which 100 subjects will be randomly assigned to placebo or bupropion for 12 weeks with follow-up assessments 4 weeks following treatment.

 Adaptive randomization will be used to balance treatment groups based on gender.

.

 Bupropion for the Treatment of Methamphetamine Dependence - 1@highlight

The purpose of this study is to assess the efficacy and safety of bupropion in reducing methamphetamine use in subjects with methamphetamine dependence